Loading market data...
markets

How S&P 500 Giant Pfizer Is Tackling Hard-To-Treat Cancers

Yahoo Finance
Read Full Article at Yahoo Finance
Share:PostShare
Ad Slot — In-Article (728x90)

Pfizer said Sunday its Braftovi-tied regimen nearly doubled the length of time colon cancer patients lived without getting sicker.

This is a summary. For the full story, read the original article at Yahoo Finance.

Original source: Yahoo Finance

Ad Slot — Below Article (300x250)